SGLT2 & GLP-1 in Diabetes
This AR tool opens up a hands-on virtual world discussing type 2 diabetes
About SGLT2 & GLP-1 in Diabetes
This tool can be used for peer-to-peer, physician-to-patient, and physician-to-caregiver discussions, allowing you to virtually explore two important drug classes used in type 2 diabetes: SGLT2 inhibitors and GLP-1 receptor agonists. The benefits of these agents are carefully described, matched to a visually engaging depiction of their glucose-lowering mechanisms and their effects on different organ systems.
Similar Apps
Understanding Rett Syndrome
This Augmented Reality App invites you to experience an interactive journey illustrating...
Multiple Myeloma Management
Bispecific antibodies are a novel mechanism in the management in the relapsed/refractory...
Updates in NHL Management
In the management of non-Hodgkin lymphoma (NHL), multiple mechanisms of therapy have...
Squamous Cell Cancer, Head/Nec
Squamous cell carcinomas of the head and neck (SCCHN) are a group...
Understanding RVO
Learn more about retinal vein occlusion (RVO) with this augmented reality animation....
Managing Atopic Dermatitis
This augmented reality tool helps bring science to life as you virtually...
